IVERIC bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
29.17
|
|
Average Rating
|
4.42
|
|
# Strong Buys
|
7
|
|
# Buys
|
3
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.40
|
-0.35
|
0.05
|
12.50%
|
|
2022-06-30
|
-0.31
|
-0.41
|
-0.10
|
-32.26%
|
|
2022-03-31
|
-0.29
|
-0.29
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.24
|
-0.29
|
-0.05
|
-20.83%
|
|
2021-09-30
|
-0.29
|
-0.23
|
0.06
|
20.69%
|
|
2021-06-30
|
-0.26
|
-0.32
|
-0.06
|
-23.08%
|
|
2021-03-31
|
-0.25
|
-0.29
|
-0.04
|
-16.00%
|
|
2020-12-31
|
-0.26
|
-0.27
|
-0.01
|
-3.85%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.05
|
|
2021-12-31
|
-1.13
|
|
2020-12-31
|
-1.14
|
|
2019-12-31
|
-1.39
|
|
2018-12-31
|
-1.67
|
|
2017-12-31
|
3.17
|
|
2016-12-31
|
-5.45
|
|
2015-12-31
|
-3.02
|
|
2014-12-31
|
-2.96
|
|
2013-12-31
|
-10.91
|